MNT for HIV and AIDS Flashcards
(122 cards)
____ million people are living with HIV worldwide
38.4
There are ____ million new cases per year worldwide
1.5
In 2021, there were ____ deaths from HIV/AIDS
650,000
Where is there the highest prevalence of HIV/AIDS?
Africa
In the U.S, there are ____ people living with HIV infection (2019)
1,189,700
In 2020, there were ___ new cases of HIV infection in the US
30,635
In 2020, there were ____ deaths from HIV/AIDS in the US
18,489
HIV/AIDS is more common in what sex?
Males
What race has a higher prevalence of HIV/AIDS in the US?
Black Americans
HIV/AIDS is caused by a primary infection with the ___ ____ ____
Human Immunodeficiency Virus
HIV is a ____, which is an enveloped RNA virus that replicates using the enzyme reverse transcriptase to copy RNA into DNA
Retrovirus
HIV invades the genetic core of the ___ ___ ___ cells and replicates
CD4+ T-helper lymphocyte
HIV infection causes a progressive depeletion of CD4+ cells which causes _____
Immunodeficiency
What are possible transmission vehicles of HIV?
-Blood
-Semen
-Vaginal secretions
-Breast milik
The most common methods of transmission is through ___ ___
Sexual contact
Another common method of transmission is sharing contaminated ___, or injection of or contact with contaminated blood products
Needles
HIV can also be spread ____, which means in utero, during birth, or during breast feeding
Perinatal
To diagnose HIV, ___ ____ is done and the window period is up to 3 months
Antibody testing
The two main biomarkers used to assess disease progression are…
-CD4+ T-cell count
-Viral load
____ HIV infection is the period from the transmission to the host until the production of detectable antibodies against the virus (seroconversion)
Acute
Initial symptoms of seroconversion (acute HIV)
-Fever
-Malaise
-Pharyngitis
-Mylagia
-Swollen lymph glands
Initial symptoms occur within ___-___ weeks of infection
2-4
Initial symptoms last for ___-___ weeks
1-2
The acute HIV period has rapid viral replication prior to the development of an HIV-specific ___ ___
Immune response